These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 14972667

  • 1. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
    Swoboda H, Demal U, Krautgartner M, Amering M.
    J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
    [Abstract] [Full Text] [Related]

  • 2. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D, Starcevic V, Hannan A, Milicevic D, Lamplugh C, Fenech P.
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
    Buigues J, Vallejo J.
    J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
    [Abstract] [Full Text] [Related]

  • 4. An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder.
    Gelernter CS, Stein MB, Tancer ME, Uhde TW.
    J Clin Psychiatry; 1992 Jan; 53(1):23-7. PubMed ID: 1737736
    [Abstract] [Full Text] [Related]

  • 5. Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder.
    Kikuchi M, Komuro R, Oka H, Kidani T, Hanaoka A, Koshino Y.
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):639-43. PubMed ID: 16401237
    [Abstract] [Full Text] [Related]

  • 6. Panic and avoidance in panic disorder with agoraphobia: clinical relevance of change in different aspects of the disorder.
    Ramnerö J, Ost LG.
    J Behav Ther Exp Psychiatry; 2007 Mar; 38(1):29-39. PubMed ID: 16797483
    [Abstract] [Full Text] [Related]

  • 7. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
    Monkul ES, Tural U, Onur E, Fidaner H, Alkin T, Shear MK.
    Depress Anxiety; 2004 Mar; 20(1):8-16. PubMed ID: 15368591
    [Abstract] [Full Text] [Related]

  • 8. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA, Saeed SA, Bruce TJ.
    J Clin Psychiatry; 1996 Mar; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [Abstract] [Full Text] [Related]

  • 9. [Group psychotherapy in patients with panic disorder and agoraphobia].
    Scheibe G, Albus M, Walther AU, Schmauss M.
    Psychother Psychosom Med Psychol; 1993 Jul; 43(7):238-44. PubMed ID: 8337352
    [Abstract] [Full Text] [Related]

  • 10. Panic disorder and dissociation - comparison with healthy controls.
    Pastucha P, Prasko J, Grambal A, Latalova K, Sigmundova Z, Sykorova T, Tichackova A.
    Neuro Endocrinol Lett; 2009 Jul; 30(6):774-8. PubMed ID: 20038926
    [Abstract] [Full Text] [Related]

  • 11. Panic disorder subtypes: further clinical differences.
    Onur E, Alkin T, Tural U.
    Depress Anxiety; 2007 Jul; 24(7):479-86. PubMed ID: 17106872
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis.
    Piccinni A, Maser JD, Bazzichi L, Rucci P, Vivarelli L, Del Debbio A, Catena M, Bombardieri S, Dell'Osso L.
    Compr Psychiatry; 2006 Jul; 47(3):201-8. PubMed ID: 16635649
    [Abstract] [Full Text] [Related]

  • 13. The structure of lifetime panic-agoraphobic spectrum.
    Rucci P, Miniati M, Oppo A, Mula M, Calugi S, Frank E, Shear MK, Mauri M, Pini S, Cassano GB.
    J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
    [Abstract] [Full Text] [Related]

  • 14. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
    Bandelow B, Broocks A, Pekrun G, George A, Meyer T, Pralle L, Bartmann U, Hillmer-Vogel U, Rüther E.
    Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
    [Abstract] [Full Text] [Related]

  • 15. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B.
    Depress Anxiety; 2007 Sep; 24(1):1-14. PubMed ID: 16894619
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of change in cognitive therapy for panic disorder with agoraphobia.
    Hoffart A, Sexton H, Hedley LM, Martinsen EW.
    J Behav Ther Exp Psychiatry; 2008 Sep; 39(3):262-75. PubMed ID: 17727812
    [Abstract] [Full Text] [Related]

  • 17. Panic symptoms in schizophrenia: comorbidity and clinical correlates.
    Ulas H, Alptekin K, Akdede BB, Tumuklu M, Akvardar Y, Kitis A, Polat S.
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):678-80. PubMed ID: 18081631
    [Abstract] [Full Text] [Related]

  • 18. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB, Cromer KR.
    Depress Anxiety; 2008 Dec; 25(2):158-66. PubMed ID: 17351905
    [Abstract] [Full Text] [Related]

  • 19. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder.
    Meuret AE, White KS, Ritz T, Roth WT, Hofmann SG, Brown TA.
    J Psychiatr Res; 2006 Sep; 40(6):520-7. PubMed ID: 16293263
    [Abstract] [Full Text] [Related]

  • 20. The importance of separation anxiety in the differentiation of panic disorder from agoraphobia.
    Deltito JA, Perugi G, Maremmani I, Mignani V, Cassano GB.
    Psychiatr Dev; 1986 Sep; 4(3):227-36. PubMed ID: 3809157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.